Effect of substituting saturated with monounsaturated fatty acids on serum visfatin levels and insulin resistance in overweight women: A randomized cross-over clinical trial

International Journal of Food Sciences and Nutrition

Volumn 63, Issue 7, 2012, Pages 772-781

  Haghighatdoost, Fahimeh ^a   Hosseinzadeh Attar, Mohammad Javad ^a   Kabiri, Akram ^a   Eshraghian, Mohammadreza ^a   Esmaillzadeh, Ahmad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipocytokines; Fatty acids; Inflammation; MUFA; Overweight; Visfatin

Indexed keywords

CYTOKINE; IL6 PROTEIN, HUMAN; INSULIN; INTERLEUKIN 6; MONOUNSATURATED FATTY ACID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN;

ADULT; ARTICLE; BIOLOGICAL MODEL; BLOOD; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; IRAN; LOW CALORY DIET; METABOLISM; METHODOLOGY; OBESITY; PATIENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; BODY MASS INDEX; CROSS-OVER STUDIES; CYTOKINES; DIET, REDUCING; DOWN-REGULATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; IRAN; MODELS, BIOLOGICAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OVERWEIGHT; PATIENT COMPLIANCE; PATIENT DROPOUTS; SINGLE-BLIND METHOD;

EID: 84867444884     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2012.665044     Document Type: Article

References (61)

1. Aeberli I, Molinari L, Spinas G, Lehmann R, l'Allemand D, Zimmermann MB. 2006. Dietary intakes of fat and antioxidant vitamins are predictors ofsubclinical inflammation in overweight Swiss children. Am J Clin Nutr 84: 748-755.
2. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. 2000. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32: S498-504.
3. Al-Dokhi LM. 2009. Adipokines and etiopathology of metabolic disorders. Saudi Med J 30: 1123-1132.
4. Azadbakht L, Mirmiran P, Shiva N, Azizi F. 2005. General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res 75: 297-304.
5. Baranova AV. 2008. Adipokine genetics: unbalanced protein secretion by human adipose tissue as a cause of the metabolic syndrome. Genetika 44: 1338-1355 (Abstract).
6. Bellido C, López-Miranda J, Blanco-Colio LM, Pérez-Martinez P, Suriana FJ, Martin-Ventura JL, et al. 2004. Butter and walnuts, but not olive oil, elicit postprandial NF-κB activation in peripheral mononuclear blood cells from healthy male volun-teers. Am J Clin Nutr 80: 1487-1491.
7. Bos MB, de Vries JH, Feskens EJ, van Dijk SJ, Hoelen DW, Siebelink E, et al. 2010. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis 20: 591-598.
8. Brunerova L, Smejkalova V, Potockova J, Andel M. 2007. A comparison of the influence of a high-fat diet enriched in monounsaturated fatty acids and conventional diet on weight loss and metabolic parameters in obese non-diabetic and Type 2 diabetic patients. Diabetic Med 24: 533-540.
9. Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, et al. 2005. Effect of PPAR-alpha and-gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 336: 747-753.
10. Deans DA, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, et al. 2009. Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastro-esophageal malignancy. Am J Clin Nutr 89: 1164-1172.
11. De Luis DA, Aller R, Gonzalez Sagrado M, Conde R, Izaola O, Perez Castrillon JL, Romero E. 2010. Serumvisfatinconcentrations are related to dietary intake in obese patients. Ann Nutr Metab 57: 265-270.
12. Dorosti AR, Tabatabaei M. 2007. Food composition table. 1st ed., Tehran, Iran: Doniaye taghzieh. p 6-289 [in Persian].
13. Due A, Larsen TM, Hermansen K, Stender S, Holst JJ, Toubro S, et al. 2008. Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr 87: 855-862.
14. Duplus E, Glorian M, Forest C. 2000. Fatty acid regulation ofgene transcription. J Biol Chem 275: 30749-30752.
15. Esmaillzadeh A, Azadbakht L. 2008. Home use ofvegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr 88: 913-921.
16. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. 2007. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 137: 992-998.
17. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, et al. 2006. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394-397.
18. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. 2005. Visfatin: a protein secreted by visceral fat that mimics the effects ofinsulin. Science 307: 426-430.
19. Gallistl S, Sudi KM, Aigner R, Borkenstein M. 2001. Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program. Int J Obes Relat Metab Disord 25: 1640-1643.
20. Han SN, Leka LS, Lichtenstein AH, Ausman LM, Schaefer EJ, Meydani SN. 2002. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses ofadults with moderate hypercholesterolemia. J Lipid Res 43: 445-452.
21. Hotchkiss JW, Leyland AH. 2010. The relationship between body size and mortality in the linked Scottish Health Surveys: cross-sectional surveys with follow-up. Int J Obes 35(6): 838-851, doi. 10.1038/ijo.2010.207.
22. Ikeoka D, Mader JK, Pieber TR. 2010. Adiposetissue, inflammation and cardiovascular disease. Rev Assoc Med Bras 56: 116-121.
23. Institute of Medicine, Food and Nutrition Board. 2002. Dietary reference intake for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: The National Academies Press.
24. Janssen I, Katzmarzyk PT, Ross R. 2004. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79: 379-384.
25. Kalantary N, Ghafarpoor M. 2005. Research on Iranian food consumption pattern and nutritional assessment. 1st ed., Tehran: Publication center of education and research on management and programming. p 37-40 [in Persian].
26. Kelishadi R. 2007. Childhood overweight, obesity, and metabolic syndrome in developing countries. Epidemiol Rev 29: 62-76.
27. Kelishadi R, Ardalan G, Gheiratmand R, Majdzadeh R, Hosseini M, Gouya MM, The Caspian Study Group, et al. 2008. Thinness, overweight and obesity in a national sample of Iranian children and adolescents: CASPIAN Study. Child Care Health Dev 34: 44-54.
28. Klebanova EM, Balabolkin MI, Kreminskaia VM. 2007. The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development oftype 2 diabetes mellitus. Klin Med 85: 20-27 (Abstract).
29. Kovacikova M, Vitkova M, Klimcakova E, Polak J, Hejnova J, Bajzova M, et al. 2008. Visfatin expression in subcutaneous adipose tissue ofpre-menopausal women: relation to hormones and weight reduction. Eur J Clin Invest 38: 516-522.
30. 2. Inflamm Res 59: 399-405.
31. Li L, Yang G, Shi S, Yang M, Liu H, Boden G 2009. The adipose triglyceride lipase, adiponectin and visfatin are down regulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 45: 12-19.
32. Lopez-Garcia E, Schulze MB, Eung TT, Meigs JB, Rifai N, Manson JE, Hu FB. 2004. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80: 1029-1035.
33. Ma Y, Hébert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, et al. 2008. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24: 941-949.
34. Mata P, Garrido JA, Ordovas JM, Blazquez E, Alvarez-Sala LA, Rubio MJ, et al. 1992. Effect ofdietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 56: 77-83.
35. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. 2004. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
37. Moussavi N, Gavino V, Receveur O. 2008a. Is obesity related to the type ofdietary fatty acids? Public Health Nutr 11: 1149-1155.
38. Moussavi N, Gavino V, Receveur O. 2008b. Could the quality of dietary fat, and not just its quantity, be related to risk ofobesity? Obesity 16: 7-15.
39. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BWJH, Loeser RF, et al. 2004. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 79: 544-551.
40. Nomi N, Kimura K, Nishida T 2010. Release ofinterleukins 6 and 8 induced by zymosan and mediated by MAP kinase and NF-kappaB signaling pathways in human corneal fibroblasts. Invest Ophthalmol Vis Sci 51: 2955-2959.
41. Ogden CL, Carroll MD, Cutin LR, McDowell MA, Tabak CJ, Flegal KM. 2006. Prevalence of overweight and obesity in United States, 1999-2004. J Am Med Assoc 295: 1549-1555.
42. Ognjanovic S. 2001. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 26: 107-117.
43. Oita RC, Ferdinando D, Wilson S, Bunce C, Mazzatti DJ. 2010. Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt-and MAPK-independent, NF-κB-depen-dent manner. Pflugers Arch 459: 619-630.
44. Pajunen P, Jousilahti P, Borodulin K, Harald K, Tuomilehto J, Salomaa V. 2011. Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK'92 Cohort. Obesity (Silver Spring) 19: 848-852.
45. Paniagua JA, de la Sacristana AG, Sánchez E, Romero I. 2007a. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26: 434-444.
46. Paniagua JA, Gallego de laSacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, et al. 2007b. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbo-hydrate-rich diet in insulin resistant subjects. Diabetes Care 30: 1717-1723.
47. Piers LS, Walker KZ, Stoney RM, Soares MJ, O'Dea K. 2003. Substitution of saturated with monounsaturated fat in a 4-week diet affects body weight and composition ofoverweight and obese men. Br J Nutr 90: 717-727.
48. Popkin BM. 2001. The nutrition transition and obesity in developing world. JNutr 131: S871-S873.
49. Rasmussen LG, Larsen TM, Mortensen PK, Due A, Astrup A. 2007. Effect on 24-h energy expenditure of a moderate-fat diet high in monounsaturated fatty acids compared with that of a low-fat, carbohydrate-rich diet: a 6-mo controlled dietary interven-tion trial. Am J Clin Nutr 85: 1014-1022.
50. Rodŕguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G 2007. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des 13: 2169-2175.
51. Sanderson LM, de Groot PJ, Hooiveld GJ, Koppen A, Kalkhoven E, Müller M, Kersten S. 2008. Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS One3: e1681.
52. Sethi JK, Vidal-Puig A. 2005. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med 11: 344-347.
53. Sharma AM, Staels B. 2007. Review: peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92: 386-395.
54. Sheu WH, Chang TM, Lee WJ, Ou HC, Wu CM, Tseng LN, et al. 2008. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity 16: 1033-1038.
55. Siahanidou T, Margeli A, Kappis A, Papassotiriou I, Mandyla H. 2011. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein choles-terol levels and dietary long-chain polyunsaturated fatty acids. Metabolism 60: 389-393.
56. Soriguer F, Moreno F, Rojo-Martínez G, García-Fuentes E, Tinahones F, Gómez-Zumaquero JM, et al. 2003. Monounsa-turated n-9 fatty acids and adipocyte lipolysis in rats. Br J Nutr 90: 1015-1022.
57. Storka A, Vojtassakova E, Mueller M, Kapiotis S, Haider DG, Jungbauer A, Wolzt M. 2008. Angiotensin inhibition stimulates PPAR gamma and the release ofvisfatin. Eur J Clin Invest 38: 820-826.
58. van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG, et al. 2009. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue ofsubjects at risk ofmetabolic syndrome. Am J Clin Nutr 90: 1656-1664.
59. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, et al. 2001. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44: 312-319.
60. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, et al. 1996. Regulation ofPPAR gene expression by nutrition and obesity in rodents. J Clin Invest 97: 2553-2561.
61. Williams CM, Francis-Knapper JA, Webb D, Brookes CA, Zampelas A, Tredger JA, et al. 1999. Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study. Br J Nutr 81: 439-446.